Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients with cutaneous and rare subtypes of melanoma. CAR T-cell therapy uses genetically engineered versions of a patient’s immune cells to target and destroy cancer cells. … Read more
Medical science, also known as medicine, is a multidisciplinary field of study and practice that encompasses the understanding, diagnosis, treatment, and prevention of diseases and disorders affecting the human body. It integrates knowledge from various scientific disciplines, including biology, chemistry, physics, genetics, and psychology, to advance our understanding of health and illness. Medical science is … Read more
Today, medicines based on antibodies—proteins that fight infection and disease—are prescribed for everything from cancer to COVID-19 to high cholesterol. The antibody drugs are supplied by genetically-engineered cells that function as tiny protein-producing factories in the laboratory. Meanwhile, researchers have been targeting cancer, injuries to internal organs and a host of other ailments with new … Read more
Biotechnology is a multidisciplinary field that integrates biology, chemistry, genetics, and other scientific disciplines to harness biological systems and organisms for the development of useful products and technologies. It encompasses a wide range of applications, from healthcare and agriculture to industrial processes and environmental management. The core principle of biotechnology is the manipulation of living … Read more
Researchers have achieved a groundbreaking milestone by meticulously documenting the molecular transformations that convert a common form of prostate cancer into a rare and treatment-resistant small cell neuroendocrine (SCN) cancer. This revelation opens new avenues for understanding tumor evolution, potentially leading to innovative therapies to impede the development of SCN prostate cancers. Dr. Owen Witte … Read more